IBDEI0UT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14967,0)
 ;;=428.42^^81^936^52
 ;;^UTILITY(U,$J,358.3,14967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14967,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,14967,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,14967,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,14968,0)
 ;;=428.43^^81^936^51
 ;;^UTILITY(U,$J,358.3,14968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14968,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,14968,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,14968,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,14969,0)
 ;;=396.3^^81^936^10
 ;;^UTILITY(U,$J,358.3,14969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14969,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,14969,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,14969,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,14970,0)
 ;;=429.9^^81^936^28
 ;;^UTILITY(U,$J,358.3,14970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14970,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,14970,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,14970,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,14971,0)
 ;;=453.79^^81^936^27
 ;;^UTILITY(U,$J,358.3,14971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14971,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,14971,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,14971,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,14972,0)
 ;;=453.89^^81^936^1
 ;;^UTILITY(U,$J,358.3,14972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14972,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,14972,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,14972,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,14973,0)
 ;;=454.2^^81^936^85
 ;;^UTILITY(U,$J,358.3,14973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14973,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,14973,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,14973,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,14974,0)
 ;;=397.1^^81^936^74
 ;;^UTILITY(U,$J,358.3,14974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14974,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,14974,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,14974,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,14975,0)
 ;;=397.0^^81^936^75
 ;;^UTILITY(U,$J,358.3,14975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14975,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,14975,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,14975,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,14976,0)
 ;;=414.3^^81^936^17
 ;;^UTILITY(U,$J,358.3,14976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14976,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,14976,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,14976,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,14977,0)
 ;;=414.4^^81^936^16
 ;;^UTILITY(U,$J,358.3,14977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14977,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,14977,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,14977,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,14978,0)
 ;;=425.11^^81^936^60
 ;;^UTILITY(U,$J,358.3,14978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14978,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,14978,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,14978,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,14979,0)
 ;;=425.18^^81^936^59
 ;;^UTILITY(U,$J,358.3,14979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14979,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,14979,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,14979,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,14980,0)
 ;;=V12.55^^81^936^54
 ;;
 ;;$END ROU IBDEI0UT
